The authors conclude that treatment with subcutaneous LEC may also ameliorate copper-triggered liver injury in an animal model of WD through suppressing HMGB1-mediated hepatic and systemic inflammation [96]. This evidence concerns the gene HMGB1 and Wilson disease.